Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP723015.RABoOfkSGZ1Gnx0gdPND3axt3u6A1nsVuzmk28txZAk18130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP723015.RABoOfkSGZ1Gnx0gdPND3axt3u6A1nsVuzmk28txZAk18130_assertion type Assertion NP723015.RABoOfkSGZ1Gnx0gdPND3axt3u6A1nsVuzmk28txZAk18130_head.
- NP723015.RABoOfkSGZ1Gnx0gdPND3axt3u6A1nsVuzmk28txZAk18130_assertion description "[The percentages of MUC2-positive immunostaining for cystadenomas, borderline tumors, and cystadenocarcinomas were 0% (0/12), 50% (5/10), and 70% (7/10) respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP723015.RABoOfkSGZ1Gnx0gdPND3axt3u6A1nsVuzmk28txZAk18130_provenance.
- NP723015.RABoOfkSGZ1Gnx0gdPND3axt3u6A1nsVuzmk28txZAk18130_assertion evidence source_evidence_literature NP723015.RABoOfkSGZ1Gnx0gdPND3axt3u6A1nsVuzmk28txZAk18130_provenance.
- NP723015.RABoOfkSGZ1Gnx0gdPND3axt3u6A1nsVuzmk28txZAk18130_assertion SIO_000772 10872659 NP723015.RABoOfkSGZ1Gnx0gdPND3axt3u6A1nsVuzmk28txZAk18130_provenance.
- NP723015.RABoOfkSGZ1Gnx0gdPND3axt3u6A1nsVuzmk28txZAk18130_assertion wasDerivedFrom befree-20140225 NP723015.RABoOfkSGZ1Gnx0gdPND3axt3u6A1nsVuzmk28txZAk18130_provenance.
- NP723015.RABoOfkSGZ1Gnx0gdPND3axt3u6A1nsVuzmk28txZAk18130_assertion wasGeneratedBy ECO_0000203 NP723015.RABoOfkSGZ1Gnx0gdPND3axt3u6A1nsVuzmk28txZAk18130_provenance.